Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Finance
BioMarin Pharmaceutical Inc. - SWOT Analysis

BioMarin Pharmaceutical Inc. - SWOT Analysis - new company profile report published


Print article Print article
© companiesandmarkets.com

companiesandmarkets.com
companiesandmarkets.com
2012-06-11 00:36:21 - BioMarin Pharmaceutical Inc. - SWOT Analysis - a new company profile report on companiesandmarkets.com

BioMarin Pharmaceutical Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. BioMarin Pharmaceutical Inc. - SWOT Analysis examines the company´s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

BioMarin Pharmaceutical (BioMarin) is engaged in development and commercialization of biopharmaceuticals. The company select product candidates for diseases and conditions that represent a significant unmet medical need, have well-understood biology and provide an opportunity to be first-to-market. The company primarily operates in the US. It is headquartered in Novato, California and employed 871 people as of January 21, 2011. The company recorded revenues of $376.3 million during the financial year (FY) ended December 2010,

 

 

an increase of 15.9% over FY2009. The operating profit of the company was $0.5 million during FY2010, a decrease of 96.7% over FY2009. The net profit was $205.8 million in FY2010, as compared to a net loss of $0.5 million in FY2009.

Scope of the Report

- Provides all the crucial information on BioMarin Pharmaceutical Inc. required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting BioMarin Pharmaceutical Inc. in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of BioMarin Pharmaceutical Inc.
-Data is supplemented with details on BioMarin Pharmaceutical Inc. history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from BioMarin Pharmaceutical Inc.

Reasons to Purchase

- Support sales activities by understanding your customers´ businesses better
- Understand prospective partners and suppliers
- Keep fully up to date on your competitors´ business structure, strategy and prospects
- Obtain the most up to date company information available

Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Latest Company Profile Reports www.companiesandmarkets.com/Market/All/Company-Profile?aCode=f3f ..

About Us
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.com’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.


Author:
Mike King
e-mail
Web: www.companiesandmarkets.com
Phone: London: +44 (0) 203 086 8600

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com | BidVertiser